[go: up one dir, main page]

AR097045A2 - Sistema terapéutico transdérmico - Google Patents

Sistema terapéutico transdérmico

Info

Publication number
AR097045A2
AR097045A2 ARP140102752A ARP140102752A AR097045A2 AR 097045 A2 AR097045 A2 AR 097045A2 AR P140102752 A ARP140102752 A AR P140102752A AR P140102752 A ARP140102752 A AR P140102752A AR 097045 A2 AR097045 A2 AR 097045A2
Authority
AR
Argentina
Prior art keywords
transdermal therapeutic
therapeutic system
layer
adhesive layer
silicone
Prior art date
Application number
ARP140102752A
Other languages
English (en)
Original Assignee
Novartis Ag
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37716856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR097045(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Lts Lohmann Therapie Systeme Ag filed Critical Novartis Ag
Publication of AR097045A2 publication Critical patent/AR097045A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se refiere a Sistemas Terapéuticos Transdérmicos que poseen una capa adhesiva de silicona, a Sistemas Terapéuticos Transdérmicos que proveen concentraciones en plasma específicas, a su elaboración y uso. Reivindicación 1: Un Sistema Terapéutico Transdérmico (STT) que comprende a) una capa posterior, b) una capa reservorio que comprende uno o más ingredientes farmacéuticamente activos y uno o más polímeros, c) una capa adhesiva que comprende un taquificante y un polímero de silicona.
ARP140102752A 2005-12-01 2014-07-24 Sistema terapéutico transdérmico AR097045A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74151105P 2005-12-01 2005-12-01

Publications (1)

Publication Number Publication Date
AR097045A2 true AR097045A2 (es) 2016-02-17

Family

ID=37716856

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP060104447A AR057152A1 (es) 2005-12-01 2006-10-10 Sistema terapeutico transdermico
ARP140102752A AR097045A2 (es) 2005-12-01 2014-07-24 Sistema terapéutico transdérmico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP060104447A AR057152A1 (es) 2005-12-01 2006-10-10 Sistema terapeutico transdermico

Country Status (31)

Country Link
US (3) US20070128263A1 (es)
EP (5) EP1959937A1 (es)
JP (3) JP2009517468A (es)
KR (7) KR20130143729A (es)
CN (2) CN101312717A (es)
AR (2) AR057152A1 (es)
AT (1) AT11185U1 (es)
AU (1) AU2006320919B2 (es)
BR (2) BR122013013162A2 (es)
CA (1) CA2563110A1 (es)
DE (2) DE14163637T1 (es)
DK (5) DK2292219T3 (es)
EC (1) ECSP088469A (es)
ES (1) ES2414455T3 (es)
FI (1) FI10268U1 (es)
GT (1) GT200800075A (es)
IL (4) IL191311A (es)
MA (1) MA30022B1 (es)
MY (2) MY151020A (es)
NO (1) NO20082753L (es)
NZ (1) NZ568273A (es)
PH (2) PH12013500771A1 (es)
PL (1) PL2292219T4 (es)
PT (1) PT2292219E (es)
RU (1) RU2450805C2 (es)
SG (1) SG2014014989A (es)
SI (1) SI2292219T1 (es)
TN (1) TNSN08238A1 (es)
TW (1) TWI389709B (es)
WO (1) WO2007064407A1 (es)
ZA (1) ZA200803882B (es)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
TWI541246B (zh) 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡
GB0823554D0 (en) 2008-12-24 2009-01-28 Novartis Ag Process for the preparation of optically active compounds using transfer hydrogenation
KR101656908B1 (ko) * 2009-04-17 2016-09-12 쓰리엠 이노베이티브 프로퍼티즈 컴파니 실리콘 겔 접착 구조물
WO2010129689A1 (en) * 2009-05-05 2010-11-11 Forest Laboratories Holdings Limited Milnacipran formulations
US10744086B2 (en) 2009-10-30 2020-08-18 Ix Biopharma Ltd. Fast dissolving solid dosage form
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
WO2011073362A1 (en) 2009-12-18 2011-06-23 Novartis Ag Process for the preparation of optically active compounds using pressure hydrogenation
PT2515886T (pt) * 2009-12-22 2018-05-23 Luye Pharma Ag Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivados
US10076502B2 (en) * 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
RU2578971C2 (ru) * 2010-06-17 2016-03-27 Лтс Ломанн Терапи-Системе Аг Трансдермальное введение мемантина
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
US9375510B2 (en) * 2010-07-21 2016-06-28 3M Innovative Properties Company Transdermal adhesive compositions, devices and methods
CA2807552A1 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US20120046383A1 (en) * 2010-08-19 2012-02-23 Terumo Kabushiki Kaisha Silicone rubber composition
DE19177059T1 (de) 2010-10-01 2021-10-07 Modernatx, Inc. N1-methyl-pseudouracile enthältendes ribonucleinsäuren sowie ihre verwendungen
DK2468274T3 (en) 2010-12-14 2015-08-31 Acino Ag Transdermal therapeutic system for administration of an active substance
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR101054317B1 (ko) * 2011-01-28 2011-08-08 신신제약 주식회사 리바스티그민을 함유하는 경피흡수제제
KR101317158B1 (ko) * 2011-02-18 2013-10-15 조선대학교산학협력단 갈란타민 또는 그의 염을 함유하는 경피흡수제제
JP2014511687A (ja) 2011-03-31 2014-05-19 モデルナ セラピューティクス インコーポレイテッド 工学操作された核酸の送達および製剤
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
WO2012161489A2 (ko) * 2011-05-20 2012-11-29 에스케이케미칼 주식회사 리바스티그민 함유 패취
JP6102739B2 (ja) 2011-08-31 2017-03-29 東洋インキＳｃホールディングス株式会社 貼付剤
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
HUE057725T2 (hu) 2011-10-03 2022-06-28 Modernatx Inc Módosított nukleozidok, nukleotidok és nukleinsavak és ezek felhasználása
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
HRP20220717T1 (hr) 2011-12-16 2022-07-22 Modernatx, Inc. Modificirani pripravci mrna
KR101399035B1 (ko) * 2011-12-22 2014-05-28 주식회사 트랜스덤 리바스티그민을 함유하는 경피흡수제제
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
CA2865715C (en) 2012-02-28 2018-06-19 Nichiban Co., Ltd. Transdermal patch
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
JP2015516143A (ja) 2012-04-02 2015-06-08 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ヒト疾患に関連するタンパク質の産生のための修飾ポリヌクレオチド
WO2013150542A2 (en) * 2012-04-05 2013-10-10 Sparsha Pharma International Private Limited A transdermal patch for treatment of dementia or alzheimer type dementia
WO2013187451A1 (ja) 2012-06-12 2013-12-19 株式会社 ケイ・エム トランスダーム 貼付剤
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2014028049A1 (en) * 2012-08-15 2014-02-20 Dow Corning Corporation Multi - layer transdermal drug delivery system
CN104602687A (zh) * 2012-09-03 2015-05-06 尼普洛外用药品株式会社 贴剂
KR20140038237A (ko) * 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
US20140083878A1 (en) * 2012-09-21 2014-03-27 Mylan Inc. Transdermal drug delivery device
WO2014051128A1 (ja) * 2012-09-28 2014-04-03 株式会社 ケイ・エム トランスダーム 貼付剤
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
SMT202200337T1 (it) 2012-11-26 2022-09-14 Modernatx Inc Rna modificato al livello del terminale
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
RU2560668C2 (ru) * 2013-03-04 2015-08-20 Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии" Трансдермальный седативный фармацевтический гель для лечения психоэмоциальных расстройств
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
AR095259A1 (es) * 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
EP2968248A4 (en) * 2013-03-15 2016-08-31 Nal Pharmaceutical Group Ltd TRANSDERMAL ACTIVE COMPOSITION SYSTEM WITH RIVASTIGMIN
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
US20160206568A1 (en) 2013-06-12 2016-07-21 KM Transderm Ltd. Adhesive sheet for application to the skin, and percutaneous absorption preparation using same
TWI745577B (zh) * 2013-06-12 2021-11-11 日商Ｋｍ特蘭斯達股份有限公司 經皮吸收製劑
CA2916183C (en) 2013-07-03 2022-03-29 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with electronic component
WO2015051214A1 (en) 2013-10-03 2015-04-09 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
TWI629066B (zh) 2013-10-07 2018-07-11 帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
US10987342B2 (en) 2013-10-07 2021-04-27 Teikoku Pharma Usa, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
KR101827980B1 (ko) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
WO2015087926A1 (ja) 2013-12-12 2015-06-18 久光製薬株式会社 積層型貼付剤
CN103877063A (zh) * 2014-03-24 2014-06-25 张绪伟 一种重酒石酸卡巴拉汀胶囊及其制备方法
CN106413695B (zh) 2014-04-08 2019-12-10 帝国制药美国公司 利伐斯的明透皮组合物及其使用方法
WO2015174502A1 (ja) 2014-05-15 2015-11-19 ニチバン株式会社 リバスチグミンを含有する貼付剤のための包装体
WO2015177209A1 (en) 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
CA2948221C (en) 2014-05-20 2022-11-22 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an interface mediator
WO2015177204A1 (en) 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system containing rotigotine
US10206932B2 (en) 2014-05-22 2019-02-19 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN204119542U (zh) 2014-09-24 2015-01-21 上海荣威塑胶工业有限公司 一种ptc加热器
CN104523656A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 一种卡巴拉汀缓释透皮贴剂及其制备方法
EP4483902A3 (en) 2014-12-05 2025-04-16 KM Transderm Ltd. Adhesive sheet for attachment to skin and percutaneous absorption preparation using same
DE102015107743A1 (de) 2015-05-18 2016-11-24 Bsn Medical Gmbh Silikongelbeschichtete adhäsive Schichtstruktur
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US9980921B2 (en) * 2016-06-30 2018-05-29 Taho Pharmaceuticals Ltd. Transdermal delivery system containing methylphenidate or its salts and methods thereof
JP6864968B2 (ja) 2016-08-22 2021-04-28 救急薬品工業株式会社 貼付剤
WO2018081812A2 (en) 2016-10-31 2018-05-03 Teikoku Pharma Usa, Inc. Methods of managing pain using dexmedetomidine transdermal delivery devices
CN110087641B (zh) 2016-12-20 2024-03-12 罗曼治疗系统股份公司 含有阿塞那平和聚硅氧烷或聚异丁烯的透皮治疗系统
MX382195B (es) 2016-12-20 2025-03-13 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina
KR102033686B1 (ko) * 2017-05-19 2019-10-18 보령제약 주식회사 도네페질을 함유하는 마이크로니들 경피 패치
CN111093639A (zh) 2017-09-05 2020-05-01 罗曼治疗系统股份公司 用于卡巴拉汀经皮给药的经皮治疗系统
US20210038532A1 (en) * 2018-03-13 2021-02-11 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
US20210008000A1 (en) * 2018-03-13 2021-01-14 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
JP2021515789A (ja) * 2018-03-13 2021-06-24 エルテーエス ローマン テラピー−ジステーメ アーゲー シリコーンアクリルハイブリッドポリマーを含む経皮治療システム
CN112533594A (zh) 2018-06-19 2021-03-19 罗曼治疗系统股份公司 含有卡巴拉汀的透皮治疗系统
PL3810100T3 (pl) 2018-06-20 2025-05-12 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny zawierający asenapinę
US12329862B2 (en) 2018-06-20 2025-06-17 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
KR102590643B1 (ko) 2019-01-31 2023-10-17 히사미쓰 세이야꾸 가부시키가이샤 첩부제
JP7549642B2 (ja) * 2019-07-09 2024-09-11 エルテーエス ローマン テラピー－ジステーメ アーゲー アクリルポリマーを含む活性剤含有層及びシリコーンゲル接着剤を含む皮膚接触層を含む経皮治療システム
CN114025748A (zh) * 2019-07-09 2022-02-08 罗曼治疗系统股份公司 包括包含含硅酮聚合物的含活性剂层和包含硅酮凝胶粘合剂的皮肤接触层的透皮治疗系统
CN113616625B (zh) * 2021-08-26 2023-05-30 大连科翔科技开发有限公司 一种卡巴拉汀的长效透皮贴剂
WO2024160939A1 (en) * 2023-02-01 2024-08-08 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of huperzine a

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
DE4301783C1 (de) * 1993-01-23 1994-02-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil
US6316023B1 (en) 1998-01-12 2001-11-13 Novartis Ag TTS containing an antioxidant
GB9800526D0 (en) * 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE19922662C1 (de) * 1999-05-18 2000-12-28 Sanol Arznei Schwarz Gmbh Transdermales therapeutisches System (TTS) Tolterodin enthaltend
AU1585601A (en) * 1999-11-04 2001-05-14 Xel Herbaceuticals Transdermal administration of huperzine
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US20020192243A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
WO2002045701A2 (en) * 2000-12-05 2002-06-13 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
DE10103860B4 (de) 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
EP1423127A1 (en) * 2001-08-30 2004-06-02 Ortho-Mcneil Pharmaceutical, Inc. Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
DE10159745A1 (de) * 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
PL373903A1 (en) * 2002-05-31 2005-09-19 H.Lundbeck A/S A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
WO2004037234A2 (en) * 2002-10-24 2004-05-06 Merz Pharma Gmbh & Co. Kgaa Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
KR20060127136A (ko) 2004-02-19 2006-12-11 노파르티스 아게 콜린에스테라아제 억제제의 혈관성 우울증을 치료하기 위한용도
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
EP2596889B1 (en) * 2011-11-23 2017-04-26 Sandvik Intellectual Property AB A cutting insert and a milling tool

Also Published As

Publication number Publication date
US20070128263A1 (en) 2007-06-07
EP2292219A1 (en) 2011-03-09
PH12013500772A1 (en) 2016-01-18
PH12013500771A1 (en) 2016-01-18
EP2292219B9 (en) 2015-02-18
JP2013177419A (ja) 2013-09-09
BRPI0619758A2 (pt) 2011-10-18
DK201300014U3 (da) 2013-05-13
KR20080071581A (ko) 2008-08-04
AU2006320919A1 (en) 2007-06-07
EP1959937A1 (en) 2008-08-27
DK201300014U1 (da) 2013-02-08
IL234291A (en) 2017-02-28
RU2008126459A (ru) 2010-01-20
NZ568273A (en) 2011-06-30
JP5938612B2 (ja) 2016-06-22
ZA200803882B (en) 2009-03-25
PT2292219E (pt) 2013-06-24
MA30022B1 (fr) 2008-12-01
BR122013013162A2 (pt) 2015-06-30
SI2292219T1 (sl) 2013-08-30
KR20180050441A (ko) 2018-05-14
HK1153646A1 (en) 2012-04-05
DK201600113U1 (da) 2017-01-13
KR20170033449A (ko) 2017-03-24
KR20220156666A (ko) 2022-11-25
US20140134230A1 (en) 2014-05-15
US20130266633A1 (en) 2013-10-10
FI10268U1 (fi) 2013-10-18
TWI389709B (zh) 2013-03-21
PL2292219T3 (pl) 2013-09-30
MY162986A (en) 2017-07-31
TW200732001A (en) 2007-09-01
KR20130143729A (ko) 2013-12-31
JP2016104737A (ja) 2016-06-09
JP2009517468A (ja) 2009-04-30
RU2450805C2 (ru) 2012-05-20
ES2414455T3 (es) 2013-07-19
DE202006021172U1 (de) 2013-05-07
SG2014014989A (en) 2014-06-27
EP2786748A1 (en) 2014-10-08
CN101312717A (zh) 2008-11-26
AT11185U1 (de) 2010-06-15
EP2292219B1 (en) 2013-06-12
TNSN08238A1 (en) 2009-10-30
DK2292219T3 (da) 2013-06-24
AU2006320919B2 (en) 2011-04-28
PL2292219T4 (pl) 2014-03-31
DK201300059U3 (da) 2013-05-13
EP2286802A1 (en) 2011-02-23
DK201300015Y4 (da) 2016-02-12
IL191311A (en) 2015-02-26
WO2007064407A1 (en) 2007-06-07
KR20210008440A (ko) 2021-01-21
IL234364A (en) 2016-06-30
CA2563110A1 (en) 2007-06-01
EP3235495A1 (en) 2017-10-25
DK201300015U1 (en) 2013-02-08
PH12013500772B1 (en) 2018-04-20
JP6298034B2 (ja) 2018-03-20
CN102048713A (zh) 2011-05-11
KR20140072108A (ko) 2014-06-12
DK201300059U1 (da) 2013-04-29
DK201600113Y4 (da) 2017-06-09
GT200800075A (es) 2010-06-01
IL250734A0 (en) 2017-04-30
MY151020A (en) 2014-03-31
DE14163637T1 (de) 2015-06-03
ECSP088469A (es) 2008-07-30
NO20082753L (no) 2008-08-19
AR057152A1 (es) 2007-11-21

Similar Documents

Publication Publication Date Title
AR097045A2 (es) Sistema terapéutico transdérmico
EA201001244A1 (ru) Система доставки лекарственного средства со стабилизирующим эффектом
MX2009012273A (es) Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
AR072492A1 (es) Dispositivo y administracion transdermica de estrogeno
WO2008082712A3 (en) Systems and methods for biodosimetry with biochip using gene expression signatures
DK1888127T3 (da) Fremgangsmåde til sterilisering af en medikoindretning med en hydrofil coating
CY1116638T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας
MX2012002727A (es) Sistema terapeutico transdermico para administrar fentanilo o un analogo del mismo.
AR033748A1 (es) Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
AR070031A1 (es) Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas
AR043248A1 (es) Sistema terapeutico transdermico estable a los rayos uv
MY161056A (en) Dental strip for administration of oral treatment
AR050621A1 (es) Sistema terapeutico transdermal con una capa adherente procedimiento para el siliconado de una capa de respaldo y empleo de la capa de respaldo
BRPI0411752A (pt) implantes subcutáneos apresentando liberação inicial limitada do princìpio ativo e liberação ampliada subseqüente linearmente variável do mesmo
WO2020222139A9 (en) Formulations and methods for drug instillation into the bladder and treatment of bladder ailments
ATE465724T1 (de) Transdermales therapeutisches system mit ionenpaar-mikroreservoiren
DE60128263D1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
DK2124640T3 (da) Glucoseisomerase til anvendelse i behandlingen af fruktoseintolerans
BR0313092A (pt) Sistema de liberação transdérmica aperfeiçoado
CL2008000683A1 (es) Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de la enzima de conversion de angiotensina (ace); formulacion de dosis unitaria; y uso en el tratamiento de la diabetes.
BR0008640A (pt) Dispositivo de administração transdérmica
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron
BR112012014107B8 (pt) sistema terapêutico transdérmico (tts) e processo de produção de tts
WO2012111996A3 (ko) 갈란타민 또는 그의 염을 함유하는 경피흡수제제
AR054012A1 (es) Sistema terapeutico transdermico para la adminstracion de analgesicos

Legal Events

Date Code Title Description
FC Refusal